news Ru-Pt conjugate drug could be the future for cancer therapies 16 March 2020 | By Hannah Balfour (Drug Target Review) Researchers combined cisplatin, an enhancer and a photodynamic therapy (PDT) drug into a single conjugate that had 10 times the efficacy in treating treatment resistant cancer cells.